TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
IMNM

Immunome Inc

Healthcare · Biotechnology

20.90$ +0.0% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement IMNM
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – +111.5% -35.5% -23.2%
– +18.0% +22.8% +0.0% -16.4% +15.4% +188.7% +40.6%
– – – – – – -35.5% -55.9%
– +28.3% -15.2% +88.5% +64.9% -0.8% +461.1% +34.6%
– +76.1% +213.1% +132.3% +22.9% +44.2% +67.7% +32.8%
– +33.6% +18.5% +105.6% +46.4% +234.8% +154.8% -30.7%
– – – – – – – –
– -24.8% -64.2% -73.7% -50.0% – – –
– – – – – – – –
– +171.8% -776.4% – – -9.2% -52,405.0% –
– – – – – – – –
– – – – – – – –

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?